Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
NCT07239544
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer (NSCLC)
Interventions
OTHER:
observational study
Sponsor
The First Affiliated Hospital of Soochow University